Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

862
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
862
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing Disparities: A Pragmatic Comparative Effectiveness Trial of School-Based Executive Functioning Interventions.

Evidence-based practice in child and adolescent mental health·2026
Same author

Are NHANES Data Representative of the US Population for Chemicals with Seasonal and Regional Use?

Environmental health perspectives·2025
Same author

CellCover Defines Marker Gene Panels Capturing Developmental Progression in Neocortical Neural Stem Cell Identity.

bioRxiv : the preprint server for biology·2023
Same author

Erratum: Current Breast Milk PFAS Levels in the United States and Canada: After All This Time, Why Don't We Know More?

Environmental health perspectives·2023
Same author

Current Breast Milk PFAS Levels in the United States and Canada: After All This Time, Why Don't We Know More?

Environmental health perspectives·2022
Same author

Sex Differences in Health Status and Clinical Outcomes After Nonprimary Percutaneous Coronary Intervention.

Circulation. Cardiovascular interventions·2022
Same journal

Annealed variational mixtures for disease subtyping and biomarker discovery.

Statistical applications in genetics and molecular biology·2026
Same journal

Performance of the permutation test approach with base calling errors for detecting changes in variant allele frequencies in ctDNA for a single patient.

Statistical applications in genetics and molecular biology·2026
Same journal

BLOG: Bayesian longitudinal omics with group constraints.

Statistical applications in genetics and molecular biology·2026
Same journal

AI-driven risk prediction and categorization in cystic fibrosis leveraging AttentiveLSTM and Fox Wolf Optimizer.

Statistical applications in genetics and molecular biology·2026
Same journal

Perfect collinearity not created equal: measuring and visualizing the severity of multi-collinearity of modern omics data.

Statistical applications in genetics and molecular biology·2026
Same journal

Corrigendum to: Choice of baseline hazards in joint modeling of longitudinal and time-to-event cancer survival data.

Statistical applications in genetics and molecular biology·2025
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.0K

Multiclass cancer classification based on gene expression comparison.

Sitan Yang, Daniel Q Naiman

    Statistical Applications in Genetics and Molecular Biology
    |June 12, 2014
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel gene expression analysis method for multi-class cancer classification. The approach identifies small gene sets for accurate and interpretable cancer subtyping, outperforming existing methods.

    More Related Videos

    Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
    06:52

    Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

    Published on: July 22, 2020

    6.0K
    Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
    08:00

    Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

    Published on: October 11, 2019

    9.1K

    Related Experiment Videos

    Last Updated: Apr 28, 2026

    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
    07:35

    Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

    Published on: October 11, 2018

    7.0K
    Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
    06:52

    Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

    Published on: July 22, 2020

    6.0K
    Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
    08:00

    Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

    Published on: October 11, 2019

    9.1K

    Area of Science:

    • Genomics
    • Bioinformatics
    • Computational Biology

    Background:

    • Cancer complexity and heterogeneity are increasingly understood through genomic analysis.
    • Microarray-based cancer classification using molecular markers is a growing field.
    • Multiclass classification presents significant statistical and computational challenges.

    Purpose of the Study:

    • To develop a novel statistical approach for classifying multiple cancer states using gene expression profiles.
    • To identify small sets of genes whose relative expression can effectively discriminate between cancer classes.
    • To provide transparent decision boundaries and biologically interpretable classification rules.

    Main Methods:

    • The proposed method focuses on detecting small gene sets for class discrimination.
    • Classification rules are based on the relative comparison of gene expression values within these sets.
    • The approach was tested on seven gene expression datasets and a large leukemia cohort.

    Main Results:

    • The novel method achieved comparable or superior results to established classifiers like support vector machines and random forests.
    • The approach demonstrated effectiveness in classifying a large cohort of leukemia patients.
    • Integration with pathway analysis enhanced classification accuracy and biological relevance.

    Conclusions:

    • The developed method offers an effective and interpretable approach for multiclass cancer classification.
    • It addresses the challenges posed by cancer's complexity and heterogeneity.
    • The method holds potential for advancing personalized medicine through precise cancer subtyping.